Annual Congress of the European Society of Cardiology Munich, August
|
|
- Maude Posy Rodgers
- 6 years ago
- Views:
Transcription
1 Annual Congress of the European Society of Cardiology Munich, August Gas exchange measurements during exercise show early pulmonary arterial hypertension in scleroderma patients Daniel Dumitrescu, Cathérine Seck, Pia Moinzadeh, Nicolas Hunzelmann, Stephan Rosenkranz Klinik III für Innere Medizin, Klinik für Dermatologie und Venerologie Herzzentrum der Universität zu Köln, Universitätsklinikum Köln
2 Conflict of Interest - Disclosure Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company 1. Honoraria for lectures Actelion, GSK, Lilly, Pfizer 2. Honoraria for advisory board activities 3. Participation in clinical trials Actelion, Bayer, GSK, Novartis 4. Research support Actelion, Pfizer,
3 3-Year Survival in Patients with Systemic Sclerosis: The French ItinérAIR-Sclérodermie Study 546 pts. with systemic sclerosis (w/o pulmonary fibrosis or left heart disease) Overall 3-year Survival: 91.1% 94.4% 56.3% Hachulla-E et al, Rheumatology 2009; 48:
4 Relationship between Pulmonary Microcirculation Loss and Pulmonary Artery Pressure at Rest mean PAP Lau et al., Eur Heart J 2011; published on-line May 26
5 Rationale for measurement of PETCO 2 during exercise pulmonary vascular disease Mismatch between perfusion and ventilation: Poor perfusion, good ventilation PaCO 2 > PETCO 2 pulmonary vascular disease PaCO2 = arterial pco2 PETCO2 = end-tidal PCO2 Normal value slightly < 40 mmhg Normal value around 40 mmhg normal Pulmonary ventilation-/perfusion mismatch, reflected by ventilatory efficiency: VE/VCO 2 (left) and PETCO 2 (right) normal Froim: Kroidl et al. Kursbuch Spiroergometrie. 2006
6 Likelihood of PAH, estimated by ventilatory equivalents and end-tidal CO 2 at the anaerobic threshold N=60 9 healthy controls 52 PAH patients Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest May;127(5):
7 Study design Consecutive referrals from scleroderma clinic SSc and dyspnea (known or new onset) No PH diagnosed or known from medical history n = 45 Non-invasive diagnostic work-up: Echocardiography Lung function testing 6 minute walking distance NTproBNP Cardiopulmonary exercise testing RIGHT HEART CATHETERIZATION Group 1: No PAH PAPmean < 25 mmhg n=23 Group 2: Mild PAP elevation PAPmean mmhg n=9 Group 3: High PAP elevation PAPmean > 35 mmhg n=13
8 Calculation of gas exchange parameters Measurement Calculation algorithm Peak VO 2 (ml/min) Highest average during a complete 30-s period, to the nearest 10 ml/min Peak Heart rate (1/min) Peak O 2 pulse (ml/beat) AT (ml/min) PETCO2@AT (mmhg) VE/VCO2@AT (mmhg) Highest average during the same complete 30-s period Peak VO2 peak heart rate, to the nearest 0,1 ml/beat Primarily V-slope method, but may also use end-tidal and ventilatory equivalent data, to the nearest 10 ml/min Average for the 60-s period at and immediately after the AT Average for the 60-s period at and immediately after the AT Hansen et al. Reproducibility of Cardiopulmonary Exercise Measurements in patients with pulmonary arterial hypertension. CHEST 2004;126:
9 Patient Characteristics Total Group 1 Group 2 Group 3 n M/F 9/36 6/17 2/7 1/12 Age (years) 59 ± ± ± ± 12 BMI 24.8 ± ± ± ± 3.7 FVC (% predicted) 84.1 ± ± ± ± 18.4 DLCO (% predicted) 55.2 ± ± ± ± 17.1 PAPmean (mmhg) 28.7 ± ± ± ± 8.6 PCWP (mmhg) 10.7 ± ± ± ± 3.2 CO (L/Min) 4.9 ± ± ± ± 1.0 PVR (Wood units) 4.4 ± ± ± ± 3.4
10 Diagnostic accuracy of PETCO 2 vs tricuspid pressure gradient true negative false negative false positive true positive false positive true positive true negative false negative
11 Diagnostic accuracy of PETCO 2 vs tricuspid pressure gradient true negative false negative false positive true positive false positive true positive true negative false negative
12 Diagnostic accuracy of PETCO 2 vs tricuspid pressure gradient true negative false negative AT 26 mmhg AT 31 mmhg AT 27 mmhg false positive true positive false positive true positive true negative false negative
13 Relevance of non-invasive diagnostic procedures Mean ±SD Significance (ANOVA): p < 0,05 Groups (1,2,3) 1 vs 2 1 vs 3 2 vs 3 Tricuspid pressure gradient on echocardiography (mmhg) Peak oxygen consumption (ml/min/kg) Anaerobic threshold (AT) (ml/min/kg) VE/VCO2 at the AT (no unit) PETCO2 at the AT (mmhg) PETCO2 difference between start of exercise and AT (mmhg) 1: 26,7±7,9 2: 35,8±14,8 3: 57,9±23,5 1: 15,8±3,1 2: 12,6±2,1 3: 10,3±2,9 1: 11,3±2,2 2: 9,9±2,1 3: 7,8±1,4 1: 31,4±3,6 2: 41,3±1,9 3: 45,2±9,3 1: 36,1±4,0 2: 26,5±0,9 3: 25,7±5,4 1: 3,9±2,3 2: 0,4±3,5 3: -2,5±1,4 no yes no yes yes no no yes no yes yes no yes yes no yes yes yes
14 Patient Characteristics Total Group 1 Group 2 Group 3 n M/F 9/36 6/17 2/7 1/12 Age (years) 59 ± ± ± ± 12 BMI 24.8 ± ± ± ± 3.7 FVC (% predicted) 84.1 ± ± ± ± 18.4 DLCO (% predicted) 55.2 ± ± ± ± 17.1 PAPmean (mmhg) 28.7 ± ± ± ± 8.6 PCWP (mmhg) 10.7 ± ± ± ± 3.2 CO (L/Min) 4.9 ± ± ± ± 1.0 PVR (Wood units) 4.4 ± ± ± ± 3.4
15 Correlation of DLCO with invasive hemodynamic measurements
16 Clinical importance of PETCO 2 measurement - Inclusion of postcapillary PH (PCWP > 15 mmhg)
17 Clinical importance of PETCO 2 measurement Inclusion of borderline PAH (PAPmean mmhg)
18 Conclusions - CPET is able to detect PAH in scleroderma patients. - PETCO 2 is an important parameter to detect PAH in early and late stages. - PETCO 2 is better able to detect early PAH than the estimated PAP by echo. - The PETCO 2 difference adds relevant information to the AT value. - CPET might be considered for routine screening in scleroderma patients.
19 THANK YOU FOR YOUR ATTENTION!
Assessing the Impact on the Right Ventricle
Advances in Tricuspid Regurgitation Congress of the European Society of Cardiology (ESC) Munich, August 25-29, 2012 Assessing the Impact on the Right Ventricle Stephan Rosenkranz, MD Clinic III for Internal
More informationDeveloping Pulmonary Vasculopathy in Systemic Sclerosis, Detected with Non-Invasive Cardiopulmonary Exercise Testing
Developing Pulmonary Vasculopathy in Systemic Sclerosis, Detected with Non-Invasive Cardiopulmonary Exercise Testing Daniel Dumitrescu 1,2,5 *, Ronald J. Oudiz 1,3, George Karpouzas 1,4, Arsen Hovanesyan
More informationClinical Science Working Group 6: Diagnosis & Assessment of PAH. Co-chairs: David B. Badesch, MD Marius M. Hoeper, MD. Working Group 6 Members
Clinical Science Working Group 6: Diagnosis & Assessment of PAH Co-chairs: David B. Badesch, MD Marius M. Hoeper, MD Working Group 6 Members Harm Jan Bogaard, Robin Condliffe, Robert Frantz, Dinesh Khanna,
More informationExercise Stress Testing: Cardiovascular or Respiratory Limitation?
Exercise Stress Testing: Cardiovascular or Respiratory Limitation? Marshall B. Dunning III, Ph.D., M.S. Professor of Medicine & Physiology Medical College of Wisconsin What is exercise? Physical activity
More informationNavigating the identification, diagnosis and management of pulmonary hypertension using the updated ESC/ERS guidelines
Navigating the identification, diagnosis and management of pulmonary hypertension using the updated ESC/ERS guidelines Host: Marc Humbert Speaker: Simon Gibbs Marc HUMBERT, MD, PhD Professor of Respiratory
More informationdifferent phenotypes
Pulmonary hypertension in scleroderma: different phenotypes UMR 995 Pr David LAUNAY, MD, PhD launayd@gmail.com Service de Médecine Interne. Unité d'immunologie Clinique CNRMR Maladies Systémiques et Autoimmunes
More informationUnderstanding Complex Pulmonary Hypertension through Advanced Hemodynamics
Understanding Complex Pulmonary Hypertension through Advanced Hemodynamics Franz Rischard, DO, MS Director, Pulmonary Hypertension Program Assistant Professor of Medicine University of Arizona Lillian
More informationCPX and Prognosis in Cardiovascular Disease
CPX and Prognosis in Cardiovascular Disease Anselm K. Gitt, Piergiuseppe Agostoni Herzzentrum Ludwigshafen, Germany Instituto di Cardiologia Università di Milano, Milan, Italy Cardiopulmonary exercise
More informationReal-world experience with riociguat in CTEPH
Real-world experience with riociguat in CTEPH Matthias Held Center of Pulmonary Hypertension and Pulmonary Vascular Disease, Medical Mission Hospital, Würzburg, Germany Tuesday, 29 September ERS International
More informationApproach to CPET. CPET Cases. Case 1 4/4/2018. Impaired? Cardiac factors? Ventilatory factors?
Approach to CPET CPET Cases Neil MacIntyre MD Duke University Medical Center Durham NC Impaired? Work,, /kg Cardiac factors?, /, BP, Rhythm Ventilatory factors? Ve/MVV (incl EIB, trapping), PaCO2 Gas exchange
More informationL esercizio fisico e le patologie cardiorespiratorie: dalla valutazione funzionale alla prescrizione. M. Guazzi
La Riabilitazione Interdisciplinare L esercizio fisico e le patologie cardiorespiratorie: dalla valutazione funzionale alla prescrizione M. Guazzi Università di Milano Dipartimento Cardiologia Universitaria
More informationPulmonary Hypertension: When to Initiate Advanced Therapy. Jonathan D. Rich, MD Associate Professor of Medicine Northwestern University
Pulmonary Hypertension: When to Initiate Advanced Therapy Jonathan D. Rich, MD Associate Professor of Medicine Northwestern University Disclosures Medtronic, Abbott: Consultant Hemodynamic Definition of
More informationSubmaximal exercise pulmonary gas exchange in left heart disease patients with different forms of pulmonary hypertension
Submaximal exercise pulmonary gas exchange in left heart disease patients with different forms of pulmonary hypertension Short Title: Pulmonary gas exchange in HF patients with PH Authors: * Bryan J. Taylor,
More informationFOLLOW-UP MEDICAL CARE OF SERVICE MEMBERS AND VETERANS CARDIOPULMONARY EXERCISE TESTING
Cardiopulmonary Exercise Testing Chapter 13 FOLLOW-UP MEDICAL CARE OF SERVICE MEMBERS AND VETERANS CARDIOPULMONARY EXERCISE TESTING WILLIAM ESCHENBACHER, MD* INTRODUCTION AEROBIC METABOLISM ANAEROBIC METABOLISM
More informationCTED and the Value of Exercise Testing
CTED and the Value of Exercise Testing leveraging cardiopulmonary physiology to uncover a disease even more elusive than CTEPH Paul Forfia, MD Professor of Medicine Director, PH, RHF, and PTE Programs
More informationSEMINAR FOR CLINICIANS
Graphical Data Display for Clinical Cardiopulmonary Exercise Testing Daniel Dumitrescu and Stephan Rosenkranz Klinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Cologne, Germany Abstract
More informationCase Presentation : Pulmonary Hypertension: Diagnosis and Imaging
Case Presentation 9.40-11.20: Pulmonary Hypertension: Diagnosis and Imaging Eftychia Demerouti MD, MSc, PhD Cardiologist Onassis Cardiac Surgery Center Conflicts of interest Consulting fees and fees for
More informationReal life management of CTEPH: patient case
2 nd International Congress on cardiovascular imaging in clinical practice k Real life management of CTEPH: patient case Anastasia Anthi Pulmonary Hypertension Clinic, Attikon University Hospital, Athens
More informationSurgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011
Surgery and device intervention for the elderly with heart failure: assessing the need Devices and Technology for heart failure in 2011 Assessing cardiovascular function / prognosis (in the elderly): composite
More informationClinical implication of exercise pulmonary hypertension: when should we measure it?
Clinical implication of exercise pulmonary hypertension: when should we measure it? Jang-Young, Kim Wonju College of Medicine, Yonsei Univ. Exercise pulmonary hypertension (EPH) Introduction of pulmonary
More informationPhysiological Insights of Exercise Hyperventilation in Pulmonary Hypertension
Physiological Insights of Exercise Hyperventilation in Pulmonary Hypertension Stefania Farina MD, Noemi Bruno MD, Cecilia Agalbato MD, Mauro Contini MD, Roberto Cassandro MD, Davide Elia MD, Sergio Harari
More informationΔΙΑΓΝΩΣΗ ΚΑΙ ΘΕΡΑΠΕΙΑ ΤΗΣ ΧΡΟΝΙΑΣ ΘΡΟΜΒΟΕΜΒΟΛΙΚΗΣ ΥΠΕΡΤΑΣΗΣ (CTEPH)
Aristotle University of Thessaloniki Cardiology Clinic, AHEPA Hospital ΔΙΑΓΝΩΣΗ ΚΑΙ ΘΕΡΑΠΕΙΑ ΤΗΣ ΧΡΟΝΙΑΣ ΘΡΟΜΒΟΕΜΒΟΛΙΚΗΣ ΥΠΕΡΤΑΣΗΣ (CTEPH) Charalampos I. Karvounis, MD Professor of Cardiology Aristotle
More informationΠνευμονική υπέρταση: Τα 10 πιο σημαντικά κενά και παραλείψεις των Κατευθυντήριων Οδηγιών του 2015
Πνευμονική υπέρταση: Τα 10 πιο σημαντικά κενά και παραλείψεις των Κατευθυντήριων Οδηγιών του 2015 Γεωργία Γ. Πίτσιου, MD, MSc, PhD Πνευμονολόγος- Εντατικολόγος Επίκουρη Καθηγήτρια Ιατρική Σχολή ΑΠΘ Γ.Ν.
More informationThe Case of Marco Nazzareno Galiè, M.D.
The Case of Marco Nazzareno Galiè, M.D. DIMES Disclosures Consulting fees and research support from Actelion Pharmaceuticals Ltd, Bayer HealthCare, Eli Lilly and Co, GlaxoSmithKline and Pfizer Ltd Clinical
More informationPrognostic Value of Blood Gas Analyses in Patients with Idiopathic Pulmonary Arterial Hypertension
ERJ Express. Published on February 14, 2007 as doi: 10.1183/09031936.00134506 Revision 2 Prognostic Value of Blood Gas Analyses in Patients with Idiopathic Pulmonary Arterial Hypertension Running title:
More informationCardiopulmonary exercise test among children with congenital heart diseases: a multicenter study
Cardiopulmonary exercise test among children with congenital heart diseases: a multicenter study Pascal AMEDRO, MD, PhD, Arthur Gavotto, MD, Sophie GUILLAUMONT, MD, Stefan MATECKI, MD, PhD Pediatric and
More informationIvana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic, A Djordjevic Dikic, B Beleslin, M Nikolic, M Petrovic, D Popovic
Combined cardiopulmonary exercise stress echocardiography test: New test for assessment of diastolic dysfunction in patients with hypertension Ivana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic,
More informationAccuracy of the ST/HR hysteresis and of cardiopulmonary stress testing parameters in the diagnosis of exercise induced myocardial ischemia
G. D ANNUNZIO UNIVERSITY - CHIETI FACULTY OF MEDECINE DEPARTMENT OF CARDIOLOGY Director: Prof. R. De Caterina Accuracy of the ST/HR hysteresis and of cardiopulmonary stress testing parameters in the diagnosis
More informationCardiopulmonary Exercise Testing Cases
Canadian Respiratory Conference - 217 Cardiopulmonary Exercise Testing Cases Darcy D Marciniuk, MD FRCPC FCCP Associate Vice-President Research, University of Saskatchewan Professor, Respirology, Critical
More informationWhat is controversial in diagnostic imaging?
Controversies in the management of pulmonary hypertension What is controversial in diagnostic imaging? G. Derumeaux Lyon University Hospices Civils de Lyon France Déclaration de Relations Professionnelles
More informationTHERAPEUTICS IN PULMONARY ARTERIAL HYPERTENSION Evidences & Guidelines
THERAPEUTICS IN PULMONARY ARTERIAL HYPERTENSION Evidences & Guidelines Vu Nang Phuc, MD Dinh Duc Huy, MD Pham Nguyen Vinh, MD, PhD, FACC Tam Duc Cardiology Hospital Faculty Disclosure No conflict of interest
More informationCase Report Pulmonary Hypertension in Pulmonary Langerhans Cell Granulomatosis
Case Reports in Medicine Volume 0, Article ID 378467, 5 pages doi:0.55/0/378467 Case Report Pulmonary Hypertension in Pulmonary Langerhans Cell Granulomatosis Matthias Held, Philipp Schnabel, Arne Warth,
More informationPatients with right-to-left intracardiac shunts regulate arterial
Gas Exchange Detection of Exercise-Induced Right-to-Left Shunt in Patients With Primary Pulmonary Hypertension Xing-Guo Sun, MD; James E. Hansen, MD; Ronald J. Oudiz, MD; Karlman Wasserman, MD, PhD Background
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationA THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY: Monika Sattler
IS THERE A RELATIONSHIP BETWEEN CHANGE IN DISEASE SEVERITY AND CHANGE IN GAS EXCHANGE DURING A SIX-MINUTE WALK TEST IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION? A THESIS SUBMITTED TO THE
More informationDisclosures. Inhaled Therapy in Pediatric Pulmonary Hypertension. Inhaled Prostacyclin: Rationale. Outline
Disclosures Inhaled Therapy in Pediatric Pulmonary Hypertension The University of Colorado receives fees for Dr Ivy to be a consultant for Actelion, Gilead, Lilly, Pfizer, and United Therapeutics Dunbar
More informationClinical History. CHD-PAH Case: Physical Exam. Clinical History. To Repair or not to Repair?
CHD-PAH Case: To Repair or not to Repair? Erika Berman Rosenzweig, MD Columbia University, College of Physicians and Surgeons Clinical History 18 year old female had been previously well, but new murmur
More informationFUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART
FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART CINDY BITHER, MSN, ANP, ANP, AACC, CHFN CHIEF NP, ADV HF PROGRAM MEDSTAR WASHINGTON HOSPITAL CENTER CONFLICTS OF INTEREST NONE
More informationCardiopulmonary Exercise Test (CPET) Evaluation Report
Cardiopulmonary Exercise Test (CPET) Evaluation Report Name: Sally Alpha Date: Test 1 November 29, 2015 Test 2 November 30, 2015 Findings: Sally Alpha demonstrates poor functional capacity and early onset
More informationDyspnea is a common exercise-induced
MK pg 214 Mædica - a Journal of Clinical Medicine STATE-OF-THE-ART Cardiopulmonary exercise testing in differential diagnosis of dyspnea Nora TOMA, MD; Gabriela BICESCU, MD, PhD; Raluca ENACHE, MD; Ruxandra
More informationJames E. Hansen, MD, FCCP; Gaye Ulubay, MD; Bing Fai Chow, MD; Xing-Guo Sun, MD; and Karlman Wasserman, PhD, MD, FCCP
CHEST Original Research EXERCISE TESTING Mixed-Expired and End-Tidal CO 2 Distinguish Between Ventilation and Perfusion Defects During Exercise Testing in Patients With Lung and Heart Diseases* James E.
More informationMeet the expert ME6 Heart failure-copd overlap and cardiovascular responses to exercise: a cardiologist s perspective
ERS Annual Congress Milan 09 13 September 2017 Meet the expert ME6 Heart failure-copd overlap and cardiovascular responses to exercise: a cardiologist s perspective Monday, 11 September 2017 13:00-14:00
More informationPulmonary hypertension in clinical practice: are we focusing on the problem?
Pulmonary hypertension in clinical practice: are we focusing on the problem? Odd Bech-Hanssen, MD, PhD Cardiology/Clinical Physiology Sahlgrenska University Hospital Gothenburg, Sweden Definition Mean
More informationThe Hemodynamics of PH Interpreting the numbers
The Hemodynamics of PH Interpreting the numbers Todd M Bull MD Associate Professor of Medicine Division of Pulmonary Sciences and Critical Care Medicine Pulmonary Hypertension Center University of Colorado
More informationPulmonary Hypertension: Echocardiographic Evaluation of Pulmonary Hypertension and Right Ventricular Function. Irmina Gradus-Pizlo, MD
Pulmonary Hypertension: Echocardiographic Evaluation of Pulmonary Hypertension and Right Ventricular Function Irmina Gradus-Pizlo, MD Disclosures: Nothing to disclose Overview Is pulmonary hypertension
More informationThe REDUCE LAP Heart Failure Trial. David M Kaye MD, PhD on behalf of the REDUCE LAP HF Investigators
Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial David M Kaye
More informationPrimary pulmonary hypertension (PPH) is a progressive
Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension Xing-Guo Sun, MD; James E. Hansen, MD; Ronald J. Oudiz, MD; Karlman Wasserman, MD, PhD Background Patients with primary pulmonary
More informationSATELLITE SYMPOSIUM OF MSD. sgc Stimulation for the treatment of PH. Real life management of PAH: case presentation
SATELLITE SYMPOSIUM OF MSD sgc Stimulation for the treatment of PH Real life management of PAH: case presentation Eftychia Demerouti MD, MSc, PhD Cardiologist Onassis Cardiac Surgery Center Conflict of
More informationPulmonary hypertension is a devastating. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Eur Respir J 2012; 39: 119 124 DOI: 10.1183/09031936.00109710 CopyrightßERS 2012 Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients S.J. Scheidl*, C. Englisch #, G. Kovacs*,
More informationRight ventricular free wall motion abnormalities as a simple method of assessment in patients with pulmonary hypertension (RCD code: II 1A.
Journal of Rare Cardiovascular Diseases 2017; 3 (5): 161 167 www.jrcd.eu ORIGINAL PAPER Rare diseases of pulmonary circulation Right ventricular free wall motion abnormalities as a simple method of assessment
More informationObjective: Prepare NBRC candidate for CRT and WRT Content Outline
STRESS TEST AND HEMODYNAMICS Lois Rowland, MS, RRT-NPS, RPFT, FAARC Objective: Prepare NBRC candidate for CRT and WRT Content Outline Perform, evaluate patient response to, interpret results from: Stress
More informationScreening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden
Screening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden m.v.huisman@lumc.nl Background CETPH Chronic Thrombo Embolic Pulmonary Hypertension
More information11/12/2018. Prof. Steven S. Saliterman. Options. Prof. Paul Iaizzo s Physiology Lab, PHSL 3701
Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Prof. Paul Iaizzo s Physiology Lab, PHSL 3701 Options University of Minnesota Bricker, E. Compass, 5 Types of Cardiac
More informationCorrespondence should be addressed to Jinming Liu;
Hindawi BioMed Research International Volume 2017, Article ID 3415401, 8 pages https://doi.org/10.1155/2017/3415401 Research Article The Correlation of Decreased Heart Rate Recovery and Chronotropic Incompetence
More informationCardiopulmonary Exercise Testing
Cardiopulmonary Exercise Testing Normal Responses and Important Concepts Carl D. Mottram, RRT RPFT FAARC Director - Pulmonary Function Labs and Rehabilitation Associate Professor of Medicine - Mayo Clinic
More informationThe Case of Lucia Nazzareno Galiè, M.D.
The Case of Lucia Nazzareno Galiè, M.D. DIMES Disclosures Consulting fees and research support from Actelion Pharmaceuticals Ltd, Bayer HealthCare, Eli Lilly and Co, GlaxoSmithKline and Pfizer Ltd Clinical
More informationELIGIBILITY CRITERIA FOR PULMONARY ARTERIAL HYPERTENSION THERAPY
ELIGIBILITY CRITERIA FOR PULMONARY ARTERIAL HYPERTENSION THERAPY Contents Eligibility criteria for Pulmonary Arterial Hypertension therapy...2-6 Initial Application for funding of Pulmonary Arterial Hypertension
More informationBasics of Cardiopulmonary Exercise Test Interpretation. Robert Kempainen, MD Hennepin County Medical Center
Basics of Cardiopulmonary Exercise Test Interpretation Robert Kempainen, MD Hennepin County Medical Center None Conflicts of Interest Objectives Explain what normally limits exercise Summarize basic protocol
More informationDisclosures. Objectives. RV vs LV. Structure and Function 9/25/2016. A Look at the Other Side: Focus on the Right Ventricle and Pulmonary Hypertension
Disclosures A Look at the Other Side: Focus on the Right Ventricle and Pulmonary Hypertension No financial relationships Susan P. D Anna MSN, APN BC, CHFN September 29, 2016 Objectives RV vs LV Differentiate
More informationNBRC Exam RPFT Registry Examination for Advanced Pulmonary Function Technologists Version: 6.0 [ Total Questions: 111 ]
s@lm@n NBRC Exam RPFT Registry Examination for Advanced Pulmonary Function Technologists Version: 6.0 [ Total Questions: 111 ] https://certkill.com NBRC RPFT : Practice Test Question No : 1 Using a peak
More informationTyrosine Kinase Inhibitors
European Society of Cardiology ESC CONGRESS 2011 aris, August 27-31, 2011 New Approaches to the Treatment of ulmonary Hypertension: Tyrosine Kinase Inhibitors Stephan Rosenkranz Klinik III für Innere Medizin
More informationTesting Clinical Implications
Cardiopulmonary Exercise Testing Clinical Implications Dr Sahajal Dhooria Outline Basic concepts Case studies Recent advances in clinical applications of CPET Basic Concepts Exercise Any physical activity
More informationRole of Combination PAH Therapies
Role of Combination PAH Therapies Ronald J. Oudiz, MD, FACP, FACC Associate Professor of Medicine, David Geffen School of Medicine at UCLA Director, Liu Center for Pulmonary Hypertension Los Angeles Biomedical
More informationHeart failure is one of the most important
Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2013; 8(2): 124-128 ORIGINAL PAPERS Worsening of Heart Failure after Abdominal Surgery Can we predict it? Nora TOMA; Ruxandra
More informationSTARTS-1 and -2. Barst R, Ivy DD, et al. Circulation 2012;125:
STARTS-1 and -2 A randomized, double-blind,16 week placebo controlled, dose ranging, parallel group study of oral monotherapy sildenafil in treatment naive children, aged 1-17 years, with pulmonary arterial
More informationPADN-5 Trial. Pulmonary artery denervation significantly increases 6-minute walk distance for patients with CpcPH: The PADN-5 Study
PADN-5 PADN-5 Trial Pulmonary artery denervation significantly increases 6-minute walk distance for patients with CpcPH: The PADN-5 Study Shao-Liang Chen, MD Hang Zhang, Juan Zhang, Mengxuan Chen, Dujiang
More informationΠνευμονική Υπέρταση: Μια ΚΡΙΤΙΚΗ ματιά στις κλινικές μελέτες - AMBITION. Αναστασία Ανθη
Πανελλήνια Σεμινάρια Ομάδων Εργασίας 2017 k Πνευμονική Υπέρταση: Μια ΚΡΙΤΙΚΗ ματιά στις κλινικές μελέτες - AMBITION Αναστασία Ανθη Β Κλιν. Εντατικής Θεραπείας & Διακλινικό Ιατρείο Πνευμ. Υπέρτασης Π.Γ.Ν.
More informationPULMONARY HYPERTENSION
PULMONARY HYPERTENSION REVIEW & UPDATE Olga M. Fortenko, M.D. Pulmonary & Critical Care Medicine Pulmonary Vascular Diseases Sequoia Hospital 650-216-9000 Olga.Fortenko@dignityhealth.org Disclosures None
More informationLessons From An Advanced Dyspnea Center: New Approaches to An Old Problem. Robert Schilz DO, PhD
Lessons From An Advanced Dyspnea Center: New Approaches to An Old Problem Robert Schilz DO, PhD Conflict of Interest Statement Robert Schilz DO, PhD No conflicts relevant to this talk Introduction, Definitions,
More informationCardiogenic shock: Current management
Cardiogenic shock: Current management Janine Pöss Universitätsklinikum des Saarlandes Klinik für Innere Medizin III Kardiologie, Angiologie und internistische Intensivmedizin Homburg/Saar I have nothing
More informationCharacterization of Patients With Borderline Pulmonary Arterial Pressure
[ Original Research Pulmonary Vascular Disease ] Characterization of Patients With Borderline Pulmonary Arterial Pressure Gabor Kovacs, MD ; Alexander Avian, PhD ; Maria Tscherner, MD ; Vasile Foris, MD
More informationGuide to the interpretation of Cardiopulmonary Exercise Testing
Guide to the interpretation of Cardiopulmonary Exercise Testing Dr. Ines Frederix December 2014 Copyright: Ines Frederix 1 Ergospirometry: parameter description... 5 1.1 Cardiovascular parameters... 5
More informationOntario s Referral and Listing Criteria for Adult Lung Transplantation
Ontario s Referral and Listing Criteria for Adult Lung Transplantation Version 3.0 Trillium Gift of Life Network Adult Lung Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient
More informationIdentification and Treatment of the Patient with Sleep Related Hypoventilation
Identification and Treatment of the Patient with Sleep Related Hypoventilation Hillary Loomis-King, MD Pulmonary and Critical Care of NW MI Munson Sleep Disorders Center X Conflict of Interest Disclosures
More informationPulmonary vascular response patterns during exercise in interstitial lung disease
ORIGINAL ARTICLE PULMONARY VASCULAR DISEASES Pulmonary vascular response patterns during exercise in interstitial lung disease Luiza H. Degani-Costa 1,2, Barbara Levarge 2, Subba R. Digumarthy 3, Aaron
More informationInterest of PVO2 assesment in HFpEF patients
Interest of PVO2 assesment in HFpEF patients Jean Yves TABET CRCB, Villeneuve Saint Denis Institut Jacques Cartier, Massy Conflits of interest none Interest of PVO2 in HFr EF Evaluation of exercise tolerance
More informationPREOPERATIVE CARDIOPULMONARY ASSESSMENT FOR LIVER TRANSPLANTATION James Y. Findlay Mayo Clinic College of Medicine, Rochester, MN, USA.
PREOPERATIVE CARDIOPULMONARY ASSESSMENT FOR LIVER TRANSPLANTATION James Y. Findlay Mayo Clinic College of Medicine, Rochester, MN, USA Introduction Liver transplantation (LT) has gone from being a high-risk
More informationClinical exercise testing
Basic principles of clinical exercise testing Clinical exercise testing This article is adapted from the on Basic principles of clinical exercise testing organised in Rome, March 2 4, 2006. Original slides,
More informationPathophysiology Department
UNIVERSITY OF MEDICINE - PLOVDIV Pathophysiology Department 15A Vasil Aprilov Blvd. Tel. +359 32 602311 Algorithm for interpretation of submaximal exercise tests in children S. Kostianev 1, B. Marinov
More informationTREPROSTINIL Generic Brand HICL GCN Exception/Other TREPROSTINIL REMODULIN 23650
Generic Brand HICL GCN Exception/Other TREPROSTINIL REMODULIN 23650 SODIUM TREPROSTINIL TYVASO 36537 36539 36541 TREPROSTINIL ORENITRAM 40827 **Please use the criteria for the specific drug requested**
More informationScleroderma and PAH Overview. PH Resource Network Martha Kingman, FNP C UTSW Medical Center at Dallas
Scleroderma and PAH Overview PH Resource Network 2007 Martha Kingman, FNP C UTSW Medical Center at Dallas Scleroderma and PAH Outline: Lung involvement in scleroderma Evaluation of the scleroderma patient
More informationCharacteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients
Pudasaini et al. BMC Cardiovascular Disorders (2018) 18:56 https://doi.org/10.1186/s12872-018-0783-7 RESEARCH ARTICLE Open Access Characteristics of exercise capacity in female systemic lupus erythematosus
More informationPerformance Enhancement. Cardiovascular/Respiratory Systems and Athletic Performance
Performance Enhancement Cardiovascular/Respiratory Systems and Athletic Performance Functions of the Cardiovascular System Deliver oxygen & nutrients to body tissues Carry wastes from the cells Anatomy
More informationCardiopulmonary Exercise Testing (CPET) & Evaluating Functional Capacity
Cardiopulmonary Exercise Testing (CPET) & Evaluating Functional Capacity Staci R. Stevens, MA Executive Director Pacific Fatigue Laboratory University of the Pacific sstevens@pacific.edu Christopher Snell,
More informationDisclosures. Objectives 6/16/2016. A Look at the Other Side: Focus on the Right Ventricle and Pulmonary Hypertension
A Look at the Other Side: Focus on the Right Ventricle and Pulmonary Hypertension Susan P. D Anna MSN, APN-BC, CHFN June 24, 2016 Disclosures Objectives Differentiate structure and function of RV and LV
More informationFrom Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension
From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension Dr Rachel Davies Respiratory Physician National Pulmonary Hypertension Service Hammersmith Hospital Royal College of Physicians
More informationDespite updated guidelines and advances. Early detection and management of pulmonary arterial hypertension REVIEW
Eur Respir Rev 212; 21: 126, 36 312 DOI: 1.1183/95918.5112 CopyrightßERS 212 REVIEW Early detection and management of pulmonary arterial hypertension Marc Humbert*, J. Gerry Coghlan # and Dinesh Khanna
More informationPulmonary arterial hypertension (PAH) is
Eur Respir Rev 21; 19: 118, 314 32 DOI: 1.1183/95918.781 CopyrightßERS 21 REVIEW Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease
More informationSclérodermie systémique Hypertension artérielle pulmonaire (excepté la thérapeutique)
DU maladies systémiques 13 octobre 2017 Sclérodermie systémique Hypertension artérielle pulmonaire (excepté la thérapeutique) Luc Mouthon Service de Médecine Interne, hôpital Cochin, Centre de Référence
More informationBlood Pressure in Exercise Prof. Dr. Alfred Hager
Blood Pressure in Exercise Prof. Dr. Alfred Hager Department of Pediatric Cardiology and Congenital Heart Disease Head of Outpatient Section Head of Exercise Laboratory Member of DGPK Guideline Committee
More informationNothing to Disclose. Severe Pulmonary Hypertension
Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis
More informationEffective Strategies and Clinical Updates in Pulmonary Arterial Hypertension
Effective Strategies and Clinical Updates in Pulmonary Arterial Hypertension Hap Farber Director, Pulmonary Hypertension Center Boston University School of Medicine Disclosures 1) Honoria: Actelion, Gilead,
More informationPulmonary vasodilators in Fontan Patients
Pulmonary vasodilators in Fontan Patients Maurice Beghetti Pediatric Cardiology University Children s Hospital HUG and CHUV Pulmonary Hypertension Program HUG Centre Universitaire Romand de Cardiologie
More informationPulmonary Hypertension Associated with Congenital Heart Disease. Amiram Nir Hadassah, Jerusalem
Pulmonary Hypertension Associated with Congenital Heart Disease Amiram Nir Hadassah, Jerusalem Disclosure Honoraria - Actelion Research grants form Actelion The Nice Classification (2013) Blok et al. Expert
More informationΚαθετηριασμός δεξιάς κοιλίας. Σ. Χατζημιλτιάδης Καθηγητής Καρδιολογίας ΑΠΘ
Καθετηριασμός δεξιάς κοιλίας Σ. Χατζημιλτιάδης Καθηγητής Καρδιολογίας ΑΠΘ The increasing interest in pulmonary arterial hypertension (PAH), the increasing interest in implantation of LVADs, and the evolution
More informationEuropean Journal of Preventive Cardiology
European Journal of Preventive Cardiology http://cpr.sagepub.com/ Test retest repeatability of cardiopulmonary exercise test variables in patients with cardiac or respiratory disease Anthony Barron, Niti
More informationExercise stroke volume and heart rate response differ in right and left heart failure
European Journal of Heart Failure (2010) 12, 716 720 doi:10.1093/eurjhf/hfq062 Exercise stroke volume and heart rate response differ in right and left heart failure Herman Groepenhoff 1 *, Nico Westerhof
More informationAnjali Vaidya, MD, FACC, FASE, FACP Associate Director, Pulmonary Hypertension, Right Heart Failure, Pulmonary Thromboendarterectomy Program Advanced
Anjali Vaidya, MD, FACC, FASE, FACP Associate Director, Pulmonary Hypertension, Right Heart Failure, Pulmonary Thromboendarterectomy Program Advanced Heart Failure & Cardiac Transplant Temple University
More informationImproving the Detection of Pulmonary Hypertension in Systemic Sclerosis Using Pulmonary Function Tests
ARTHRITIS & RHEUMATISM Vol. 63, No. 11, November 2011, pp 3531 3539 DOI 10.1002/art.30535 2011, American College of Rheumatology Improving the Detection of Pulmonary Hypertension in Systemic Sclerosis
More informationAgenda, wednesday Dear Colleagues, 08:30-09:00 REGISTRATION over the past decades,clinical cardiopulmonary exercise testing (CPET) has evol
Piergiuseppe Agostoni Centro Cardiologico Monzino / University of Milan, Italy Stephan Baldus Germany Sponsors* Informations We thank the following partners for their kind support*: Venue Premium Sponsor
More information